{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:09:46Z","timestamp":1790500186785,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zika virus (ZIKV), a re-emerging flavivirus associated with neurological disorders, has spread rapidly to more than 70 countries and territories. However, no specific vaccines or antiviral drugs are currently available to prevent or treat ZIKV infection. Here we report that a synthetic peptide derived from the stem region of ZIKV envelope protein, designated Z2, potently inhibits infection of ZIKV and other flaviviruses <jats:italic>in vitro<\/jats:italic>. We show that Z2 interacts with ZIKV surface protein and disrupts the integrity of the viral membrane. Z2 can penetrate the placental barrier to enter fetal tissues and is safe for use in pregnant mice. Intraperitoneal administration of Z2 inhibits vertical transmission of ZIKV in pregnant C57BL\/6 mice and protects type I or type I\/II interferon receptor-deficient mice against lethal ZIKV challenge. Thus, Z2 has potential to be further developed as an antiviral treatment against ZIKV infection in high-risk populations, particularly pregnant women.<\/jats:p>","DOI":"10.1038\/ncomms15672","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T15:10:56Z","timestamp":1500995456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses"],"prefix":"10.1038","volume":"8","author":[{"given":"Yufeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Nan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Fuk-Woo Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-2807","authenticated-orcid":false,"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"BFncomms15672_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jinf.2016.02.011","volume":"72","author":"JF Chan","year":"2016","unstructured":"Chan, J. F., Choi, G. K., Yip, C. C., Cheng, V. C. & Yuen, K. Y. Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease. J. Infect. 72, 507\u2013524 (2016).","journal-title":"J. Infect."},{"key":"BFncomms15672_CR2","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1038\/emi.2016.48","volume":"5","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic. Emerg. Microbes Infect. 5, e22 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"BFncomms15672_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S1473-3099(16)30270-5","volume":"16","author":"II Bogoch","year":"2016","unstructured":"Bogoch, I. I. et al. Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study. Lancet Infect. Dis. 16, 1237\u20131245 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"BFncomms15672_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.aaf6116","volume":"352","author":"PP Garcez","year":"2016","unstructured":"Garcez, P. P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352, 816\u2013818 (2016).","journal-title":"Science"},{"key":"BFncomms15672_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2016.04.017","volume":"19","author":"C Li","year":"2016","unstructured":"Li, C. et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19, 120\u2013126 (2016).","journal-title":"Cell Stem Cell"},{"key":"BFncomms15672_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","volume":"387","author":"DL Heymann","year":"2016","unstructured":"Heymann, D. L. et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet 387, 719\u2013721 (2016).","journal-title":"Lancet"},{"key":"BFncomms15672_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"BFncomms15672_CR8","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(16)30058-7","volume":"387","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Guillain-Barre syndrome associated with Zika virus infection. Lancet 387, 1482 (2016).","journal-title":"Lancet"},{"key":"BFncomms15672_CR9","doi-asserted-by":"publisher","first-page":"e0004695","DOI":"10.1371\/journal.pntd.0004695","volume":"10","author":"J Zmurko","year":"2016","unstructured":"Zmurko, J. et al. The viral polymerase inhibitor 7-deaza-2\u2032-c-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model. PLoS Negl. Trop. Dis. 10, e0004695 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFncomms15672_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/jiw226","volume":"214","author":"L Eyer","year":"2016","unstructured":"Eyer, L. et al. Nucleoside inhibitors of Zika virus. J. Infect. Dis. 214, 707\u2013711 (2016).","journal-title":"J. Infect. Dis."},{"key":"BFncomms15672_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","volume":"496","author":"BM Carneiro","year":"2016","unstructured":"Carneiro, B. M., Batista, M. N., Braga, A. C., Nogueira, M. L. & Rahal, P. The green tea molecule EGCG inhibits Zika virus entry. Virology 496, 215\u2013218 (2016).","journal-title":"Virology"},{"key":"BFncomms15672_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","volume":"22","author":"M Xu","year":"2016","unstructured":"Xu, M. et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med. 22, 1101\u20131107 (2016).","journal-title":"Nat. Med."},{"key":"BFncomms15672_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","volume":"141","author":"JF Chan","year":"2017","unstructured":"Chan, J. F. et al. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Res. 141, 29\u201337 (2017).","journal-title":"Antiviral Res."},{"key":"BFncomms15672_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","volume":"20","author":"NJ Barrows","year":"2016","unstructured":"Barrows, N. J. et al. A screen of FDA-approved drugs for inhibitors of Zika Virus infection. Cell Host Microbe 20, 259\u2013270 (2016).","journal-title":"Cell Host Microbe"},{"key":"BFncomms15672_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696\u2013704 (2016).","journal-title":"Cell Host Microbe"},{"key":"BFncomms15672_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443\u2013447 (2016).","journal-title":"Nature"},{"key":"BFncomms15672_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/bbrc.1993.2078","volume":"195","author":"S Jiang","year":"1993","unstructured":"Jiang, S., Lin, K., Strick, N. & Neurath, A. R. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. Biochem. Biophys. Res. Commun. 195, 533\u2013538 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFncomms15672_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/365113a0","volume":"365","author":"S Jiang","year":"1993","unstructured":"Jiang, S., Lin, K., Strick, N. & Neurath, A. R. HIV-1 inhibition by a peptide. Nature 365, 113 (1993).","journal-title":"Nature"},{"key":"BFncomms15672_CR19","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1056\/NEJMoa035211","volume":"348","author":"A Lazzarin","year":"2003","unstructured":"Lazzarin, A. et al. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N. Engl. J. Med. 348, 2186\u20132195 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms15672_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm0703-839","volume":"9","author":"AS Fauci","year":"2003","unstructured":"Fauci, A. S. HIV and AIDS: 20 years of science. Nat. Med. 9, 839\u2013843 (2003).","journal-title":"Nat. Med."},{"key":"BFncomms15672_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/QAD.0b013e32832027d6","volume":"23","author":"A Furco","year":"2009","unstructured":"Furco, A. et al. Successful use of darunavir, etravirine, enfuvirtide and tenofovir\/emtricitabine in pregnant woman with multiclass HIV resistance. AIDS 23, 434\u2013435 (2009).","journal-title":"AIDS"},{"key":"BFncomms15672_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1258\/ijsa.2008.008100","volume":"19","author":"G Madeddu","year":"2008","unstructured":"Madeddu, G. et al. Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy. Int. J. STD AIDS 19, 644\u2013645 (2008).","journal-title":"Int. J. STD AIDS"},{"key":"BFncomms15672_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/jpids\/pit019","volume":"3","author":"GF Shust","year":"2014","unstructured":"Shust, G. F. et al. Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women. J. Pediatric Infect. Dis. Soc. 3, 246\u2013250 (2014).","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"BFncomms15672_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"RJ Kuhn","year":"2002","unstructured":"Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717\u2013725 (2002).","journal-title":"Cell"},{"key":"BFncomms15672_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313\u2013319 (2004).","journal-title":"Nature"},{"key":"BFncomms15672_CR26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02957-12","volume":"87","author":"DE Klein","year":"2013","unstructured":"Klein, D. E., Choi, J. L. & Harrison, S. C. Structure of a dengue virus envelope protein late-stage fusion intermediate. J. Virol. 87, 2287\u20132293 (2013).","journal-title":"J. Virol."},{"key":"BFncomms15672_CR27","doi-asserted-by":"publisher","first-page":"e1000851","DOI":"10.1371\/journal.ppat.1000851","volume":"6","author":"AG Schmidt","year":"2010","unstructured":"Schmidt, A. G., Yang, P. L. & Harrison, S. C. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog. 6, e1000851 (2010).","journal-title":"PLoS Pathog."},{"key":"BFncomms15672_CR28","doi-asserted-by":"publisher","first-page":"e50995","DOI":"10.1371\/journal.pone.0050995","volume":"7","author":"SM Lok","year":"2012","unstructured":"Lok, S. M. et al. Release of dengue virus genome induced by a peptide inhibitor. PLoS ONE 7, e50995 (2012).","journal-title":"PLoS ONE"},{"key":"BFncomms15672_CR29","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.1128\/JVI.01440-10","volume":"84","author":"AG Schmidt","year":"2010","unstructured":"Schmidt, A. G., Yang, P. L. & Harrison, S. C. Peptide inhibitors of flavivirus entry derived from the E protein stem. J. Virol. 84, 12549\u201312554 (2010).","journal-title":"J. Virol."},{"key":"BFncomms15672_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.aaf5316","volume":"352","author":"D Sirohi","year":"2016","unstructured":"Sirohi, D. et al. The 3.8A resolution cryo-EM structure of Zika virus. Science 352, 467\u2013470 (2016).","journal-title":"Science"},{"key":"BFncomms15672_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0166-0934(94)90124-4","volume":"48","author":"W Watanabe","year":"1994","unstructured":"Watanabe, W. et al. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J. Virol. Methods 48, 257\u2013265 (1994).","journal-title":"J. Virol. Methods"},{"key":"BFncomms15672_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00430-017-0493-2","volume":"206","author":"JA Muller","year":"2017","unstructured":"Muller, J. A. et al. Development of a high-throughput colorimetric Zika virus infection assay. Med. Microbiol. Immunol. 206, 175\u2013185 (2017).","journal-title":"Med. Microbiol. Immunol."},{"key":"BFncomms15672_CR33","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1128\/AAC.48.11.4349-4359.2004","volume":"48","author":"S Jiang","year":"2004","unstructured":"Jiang, S. et al. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion. Antimicrob. Agents Chemother. 48, 4349\u20134359 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms15672_CR34","first-page":"e93","volume":"5","author":"JF Chan","year":"2016","unstructured":"Chan, J. F. et al. Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs. Emerg. Microbes Infect. 5, e93 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"BFncomms15672_CR35","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1128\/JVI.00354-15","volume":"89","author":"R Hamel","year":"2015","unstructured":"Hamel, R. et al. Biology of zika virus infection in human skin cells. J. Virol. 89, 8880\u20138896 (2015).","journal-title":"J. Virol."},{"key":"BFncomms15672_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1742-4690-9-104","volume":"9","author":"L Lu","year":"2012","unstructured":"Lu, L. et al. A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains. Retrovirology 9, 104 (2012).","journal-title":"Retrovirology"},{"key":"BFncomms15672_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081\u20131091 (2016).","journal-title":"Cell"},{"key":"BFncomms15672_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","volume":"15","author":"G Lucchese","year":"2016","unstructured":"Lucchese, G. & Kanduc, D. Zika virus and autoimmunity: from microcephaly to Guillain-Barre syndrome, and beyond. Autoimmun. Rev. 15, 801\u2013808 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFncomms15672_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/cr.2016.58","volume":"26","author":"KY Wu","year":"2016","unstructured":"Wu, K. Y. et al. Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res. 26, 645\u2013654 (2016).","journal-title":"Cell Res."},{"key":"BFncomms15672_CR40","doi-asserted-by":"publisher","first-page":"e0004682","DOI":"10.1371\/journal.pntd.0004682","volume":"10","author":"MT Aliota","year":"2016","unstructured":"Aliota, M. T. et al. Characterization of lethal Zika Virus infection in AG129 mice. PLoS Negl. Trop. Dis. 10, e0004682 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFncomms15672_CR41","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.1038\/nmicrobiol.2016.87","volume":"1","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat. Microbiol. 1, 16087 (2016).","journal-title":"Nat. Microbiol."},{"key":"BFncomms15672_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1743-422X-2-49","volume":"2","author":"YM Hrobowski","year":"2005","unstructured":"Hrobowski, Y. M., Garry, R. F. & Michael, S. F. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J. 2, 49 (2005).","journal-title":"Virol. J."},{"key":"BFncomms15672_CR43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/cb1001558","volume":"5","author":"WC Wimley","year":"2010","unstructured":"Wimley, W. C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 5, 905\u2013917 (2010).","journal-title":"ACS Chem. Biol."},{"key":"BFncomms15672_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00232-011-9343-0","volume":"239","author":"WC Wimley","year":"2011","unstructured":"Wimley, W. C. & Hristova, K. Antimicrobial peptides: successes, challenges and unanswered questions. J. Membr. Biol. 239, 27\u201334 (2011).","journal-title":"J. Membr. Biol."},{"key":"BFncomms15672_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1074\/jbc.273.2.673","volume":"273","author":"B Bothner","year":"1998","unstructured":"Bothner, B., Dong, X. F., Bibbs, L., Johnson, J. E. & Siuzdak, G. Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry. J. Biol. Chem. 273, 673\u2013676 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFncomms15672_CR46","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1073\/pnas.95.12.6774","volume":"95","author":"JK Lewis","year":"1998","unstructured":"Lewis, J. K., Bothner, B., Smith, T. J. & Siuzdak, G. Antiviral agent blocks breathing of the common cold virus. Proc. Natl Acad. Sci. USA 95, 6774\u20136778 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms15672_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/cid\/ciw667","volume":"64","author":"NM Iovine","year":"2016","unstructured":"Iovine, N. M. et al. Coinfection with Zika and dengue-2 viruses in a traveler returning from Haiti, 2016: clinical presentation and genetic analysis. Clin. Infect. Dis. 64, 72\u201375 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"BFncomms15672_CR48","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/cid\/ciw589","volume":"63","author":"JJ Waggoner","year":"2016","unstructured":"Waggoner, J. J. et al. Viremia and clinical presentation in nicaraguan patients infected with Zika virus, Chikungunya virus, and dengue virus. Clin. Infect. Dis. 63, 1584\u20131590 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"BFncomms15672_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.it.2016.08.006","volume":"37","author":"AP Durbin","year":"2016","unstructured":"Durbin, A. P. Dengue antibody and Zika: friend or foe? Trends Immunol. 37, 635\u2013636 (2016).","journal-title":"Trends Immunol."},{"key":"BFncomms15672_CR50","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","volume":"113","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada, L. et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl Acad. Sci. USA 113, 7852\u20137857 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms15672_CR51","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"BFncomms15672_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature20556","volume":"540","author":"J Govero","year":"2016","unstructured":"Govero, J. et al. Zika virus infection damages the testes in mice. Nature 540, 438\u2013442 (2016).","journal-title":"Nature"},{"key":"BFncomms15672_CR53","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.cell.2016.11.016","volume":"167","author":"W Ma","year":"2016","unstructured":"Ma, W. et al. Zika virus causes testis damage and leads to male infertility in mice. Cell 167, 1511\u20131524 (2016).","journal-title":"Cell"},{"key":"BFncomms15672_CR54","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1039\/C6CS00076B","volume":"45","author":"B Oller-Salvia","year":"2016","unstructured":"Oller-Salvia, B., Sanchez-Navarro, M., Giralt, E. & Teixido, M. Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chem. Soc. Rev. 45, 4690\u20134707 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"BFncomms15672_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","volume":"17","author":"L Di","year":"2015","unstructured":"Di, L. Strategic approaches to optimizing peptide ADME properties. AAPS J. 17, 134\u2013143 (2015).","journal-title":"AAPS J."},{"key":"BFncomms15672_CR56","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.copbio.2006.10.002","volume":"17","author":"AK Sato","year":"2006","unstructured":"Sato, A. K., Viswanathan, M., Kent, R. B. & Wood, C. R. Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotechnol. 17, 638\u2013642 (2006).","journal-title":"Curr. Opin. Biotechnol."},{"key":"BFncomms15672_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11427-016-5043-4","volume":"59","author":"YQ Deng","year":"2016","unstructured":"Deng, Y. Q. et al. Isolation, identification and genomic characterization of the Asian lineage Zika virus imported to China. Sci. China Life Sci. 59, 428\u2013430 (2016).","journal-title":"Sci. China Life Sci."},{"key":"BFncomms15672_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1473-3099(16)30070-6","volume":"16","author":"FC Zhang","year":"2016","unstructured":"Zhang, F. C., Li, X. F., Deng, Y. Q., Tong, Y. G. & Qin, C. F. Excretion of infectious Zika virus in urine. Lancet Infect. Dis. 16, 641\u2013642 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"BFncomms15672_CR59","doi-asserted-by":"publisher","first-page":"e16059","DOI":"10.1371\/journal.pone.0016059","volume":"6","author":"YQ Deng","year":"2011","unstructured":"Deng, Y. Q. et al. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS ONE 6, e16059 (2011).","journal-title":"PLoS ONE"},{"key":"BFncomms15672_CR60","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/ncomms4067","volume":"5","author":"L Lu","year":"2014","unstructured":"Lu, L. et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms15672_CR61","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/1743-422X-10-266","volume":"10","author":"G Zhao","year":"2013","unstructured":"Zhao, G. et al. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol. J. 10, 266 (2013).","journal-title":"Virol. J."},{"key":"BFncomms15672_CR62","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/jac\/dkt230","volume":"68","author":"P Tong","year":"2013","unstructured":"Tong, P. et al. An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides. J. Antimicrob. Chemother. 68, 2533\u20132544 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFncomms15672_CR63","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s11095-011-0635-y","volume":"29","author":"M Tan","year":"2012","unstructured":"Tan, M. et al. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharm. Res. 29, 953\u2013960 (2012).","journal-title":"Pharm. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms15672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms15672","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncomms15672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms15672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:42:10Z","timestamp":1671756130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms15672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,8,11]]}},"alternative-id":["BFncomms15672"],"URL":"https:\/\/doi.org\/10.1038\/ncomms15672","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]},"assertion":[{"value":"2 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15672"}}